By Joe Hoppe
Aptamer Group said Monday that it has reshuffled its board and conditionally raised 3.6 million pounds ($4.6 million) in a discount share placing, and accordingly cancelled its formal sales process.
The U.K. biotechnology company said Executive Chairman Ian Gilham, Interim Chief Executive and Chief Financial Officer Rob Quinn…
Read the full article here